Theravance Biopharma, Inc.·4

May 22, 6:05 PM ET

HAUMANN BRETT K 4

4 · Theravance Biopharma, Inc. · Filed May 22, 2019

Insider Transaction Report

Form 4
Period: 2019-05-20
HAUMANN BRETT K
SVP, Clinical Development
Transactions
  • Tax Payment

    Ordinary Shares

    2019-05-20$19.84/sh2,705$53,667236,678 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -